Sun Pharma Adv Resrc Key Ratios

NSE: SPARC | BSE: 532872

₹190.16

up-down-arrow ₹-2.41 (-1.25%)

As on 20-Nov-2026IST

Market cap

info icon

₹6,189 Cr

Revenue (TTM)

info icon

₹1,932 Cr

P/E Ratio

info icon

3.8

P/B Ratio

info icon

4.3

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -24.77 282.06 3,140.97 105.09 80.89
EBIT -31.69 29.77 733.06 98.50 55.14
Net Profit -17.16 67.65 712.95 104.03 54.62
EPS -17.17 67.64 708.35 104.02 49.58
Book Value -- -- 704.47 37.52 53.06
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info -312.40-235.0584.2684.54-467.54
Net Margin info -252.26-197.4282.5882.17-465.64
Return on equity info 52.402.69118.53276.890.00
Return on Capital info -89.82-112.90--163.94-311.92
Return on Assets info -6.44-27.84163.91124.17-80.88
Debt to Equity (x) info ----0.000.42-1.19
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
--
163.94
-311.92
-112.35
-41.91
Peer Median
--
14.77
14.72
18.85
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

118.53

Higher than Peers by 107.77

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
118.53
276.89
--
-121.28
-43.41
Peer Median
10.76
12.35
11.67
14.92
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

163.91

Higher than Peers by 157.19

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
163.91
124.17
-80.88
-57.63
-26.81
Peer Median
6.72
6.87
7.86
9.06
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

84.26

Higher than Peers by 71.51

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
84.26
84.54
-467.54
-548.82
-94.57
Peer Median
12.75
13.55
15.03
14.71
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

82.58

Higher than Peers by 73.52

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
82.58
82.17
-465.64
-368.72
-89.16
Peer Median
9.06
8.30
9.33
8.49
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
0.00
83.20
-459.99
-496.00
-88.29
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

3,140.97

Higher than Peers by 3,132.12

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
3,140.97
2,518.47
-5.00
-68.36
--
Peer Median
8.85
17.50
10.27
11.85
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

735.77

Higher than Peers by 718.53

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
735.77
573.44
19.07
-83.60
--
Peer Median
17.24
24.88
24.15
28.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

712.95

Higher than Peers by 695.70

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
712.95
553.48
11.55
-73.96
--
Peer Median
17.25
36.93
30.29
36.51
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

708.35

Higher than Peers by 698.48

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
708.35
553.48
11.55
-73.96
--
Peer Median
9.87
26.79
24.50
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
--
717.12
-272.52
-75.48
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
--
0.42
-1.19
0.37
0.00
Peer Median
0.04
0.24
0.23
0.20
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
--
0.42
-0.73
0.37
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

7.65

Higher than Peers by 5.89

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
7.65
2.47
0.07
1.02
2.54
Peer Median
1.76
1.83
1.79
1.96
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

7.65

Higher than Peers by 6.45

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
7.65
2.47
0.07
1.02
2.54
Peer Median
1.20
1.19
1.47
1.44
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

58.05

Higher than Peers by 49.93

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
58.05
46.50
-36.92
-227.27
-28.15
Peer Median
8.12
7.74
9.42
8.58
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

1.10

Lower than Peers by 24.20

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
1.10
0.44
22.37
20.56
13.70
Peer Median
25.30
23.05
25.82
26.12
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

1.94

Higher than Peers by 1.27

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
1.94
1.50
0.17
0.11
0.29
Peer Median
0.66
0.79
0.75
0.77
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
--
2.36
80.33
116.55
50.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

3.78

Lower than Peers by 38.69

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
3.78
2.39
--
--
--
Peer Median
42.48
42.48
39.70
33.48
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

4.29

Higher than Peers by 0.29

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
4.29
2.78
-22.14
95.47
11.36
Peer Median
4.00
4.12
3.72
4.21
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
--
--
--
--
--
Peer Median
0.20
0.10
0.16
0.21
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

3.04

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
3.04
2.66
-15.74
-31.93
-28.11
Peer Median
--
32.33
30.23
29.90
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

6,189

Lower than Peers by 3,104

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
6,189
3,719
4,803
12,006
5,824
Peer Median
9,293
4,877
4,851
2,099
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month